Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

3.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.7K
Clinical Trials01:16

Clinical Trials

9.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.7K
Hazard Ratio01:12

Hazard Ratio

289
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
289
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

491
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
491
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

197
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
197
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

9
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
9

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From P-values to priors: revisiting the VERITAS randomized controlled trial in light of Bayes' theorem.

Chest·2026
Same author

Cryobiopsy vs Forceps for Bronchoscopic Lung Biopsy: The FROSTBITE-2 Randomized Clinical Trial.

JAMA·2026
Same author

Assessing a biomarker platform for stratifying indeterminate pulmonary nodules, protocol for the SPOT IT randomized trial.

Trials·2026
Same author

Network-based analysis of images and lesions expressed by digital interpretation and transmission of bronchoscopy findings on social media (NAILED-IT).

Respiratory medicine·2026
Same author

Temporal Trends and Mortality in Tracheobronchial Stenting in the United States: a national cohort study.

Annals of the American Thoracic Society·2026
Same author

Procedural Techniques, Airway Management, and Specimen Acquisition for Peripheral Lung Transbronchial and Endobronchial Ultrasound-Guided Cryobiopsy: A Modified Delphi Consensus Statement.

Chest·2026
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Related Experiment Video

Updated: Oct 13, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K

Joining Forces: How to Coordinate Large, Multicenter Randomized Trials.

Lance Roller1, Lonny B Yarmus2, Robert J Lentz3

  • 1Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, T-1218 MCN, Nashville, TN 37232-2650, USA.

Clinics in Chest Medicine
|November 14, 2021
PubMed
Summary
This summary is machine-generated.

Conducting multicenter randomized trials for pleural diseases requires careful planning and execution. This review highlights key elements for success and lessons learned from collaborative research networks.

Keywords:
Clinical trialsMulticenter trialPleural diseaseRandomizedResearch designs

More Related Videos

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Related Experiment Videos

Last Updated: Oct 13, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.8K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Area of Science:

  • Pulmonology and Respiratory Medicine
  • Clinical Trial Design and Methodology
  • Thoracic Diseases Research

Background:

  • Multicenter randomized trials are crucial for generating high-quality evidence in complex medical fields.
  • The study of pleural diseases has benefited significantly from collaborative research networks.
  • Existing literature often lacks a comprehensive overview of the practical aspects of conducting such trials.

Purpose of the Study:

  • To detail the advantages, disadvantages, challenges, and essential components for successfully conducting multicenter randomized trials.
  • To provide specific insights focused on trials investigating pleural diseases.
  • To share lessons learned from the development and operation of a consortium focused on interventional pulmonology outcomes.

Main Methods:

  • Review of existing literature on multicenter randomized trials in respiratory medicine.
  • Analysis of case studies and experiences from established research networks, including the Interventional Pulmonary Outcomes Group.
  • Discussion of best practices, potential pitfalls, and critical success factors in trial conduct.

Main Results:

  • Identification of key elements for successful multicenter trials, including robust network infrastructure, standardized protocols, and effective data management.
  • Acknowledgement of common challenges such as recruitment variability, logistical complexities, and inter-institutional coordination.
  • Demonstration of how dedicated networks can yield practice-changing studies in pleural disease management.

Conclusions:

  • Multicenter randomized trials are indispensable for advancing the understanding and treatment of pleural diseases.
  • Successful implementation requires meticulous planning, strong collaborative frameworks, and adaptive strategies to overcome inherent challenges.
  • The Interventional Pulmonary Outcomes Group serves as a model for generating high-quality multicenter evidence in pulmonary, pleural, and airway diseases.